Clicky

LegoChem Biosciences Inc(141080)

Description: LegoChem Biosciences, Inc. a biopharmaceutical company, focuses on the development of novel therapeutics utilizing its proprietary LegoChemistry medicinal drug discovery technology and antibody-drug conjugate platform (ADC). It engages in the research and development of ADC, anti-biotic, anti-coagulant, and anti-cancer therapeutics. The company offers its products in the forms of tablets and capsules. It has a research collaboration and license agreement with Iksuda Therapeutics for the development of antibody-drug conjugates in oncology. The company was founded in 2006 and is headquartered in Daejeon, South Korea.


Keywords: Biotechnology Biopharmaceutical Life Sciences Antibody Drug Conjugate Cancer Therapeutics Synaffix

Home Page: www.legochembio.com

8-26 Munpyeongseo-ro
Daejeon, 34302
South Korea
Phone: 82 4 2861 0688


Officers

Name Title
Mr. Yong-Zu Kim Chief Exec. Officer and Pres
Mr. Sejin Park Chief Financial Officer and VP
Mr. Yeong Soo Oh Chief Technology Officer and Exec. VP
Young Lag Cho Head Researcher
Ho Yong Song Head Researcher
Hyang Sook Lee Head Researcher
Dae Yeon Lee Head Researcher

Exchange: KQ

Country: KR

Currency: Korean Won (₩)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0
Price-to-Sales TTM: 9.512
IPO Date:
Fiscal Year End: December
Full Time Employees: 0
Back to stocks